StudyFinder



Clear

Search Results

Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.

1 Study Matches

A multinational, open-label, randomised, controlled trial to investigate efficacy and safety of NNC0365-3769 (Mim8) in adults and adolescents with haemophilia A with or without inhibitors. (NN7769-4514)

This is a drug study that will examine the safety and effectiveness of once-weekly and once-monthly Mim8 treatment in adults and adolescents (age 12 years or above) with hemophilia A with or without factor VIII (FVIII) inhibitors.

Subjects will be enrolled in 1 of the 4 study Arms. There will be 13-17 clinic visits. Blood will be drawn at most of these visits. Four physical exam will be perform throughout the study period.

$75 per visit to cover travel expenses

M. Elaine Eyster
Bree Kelly - at jhawthorne@pennstatehealth.psu.edu or 717-531-0003, ext=281498
 

All
All
This study is NOT accepting healthy volunteers
NCT05053139
STUDY00017302
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
congenital haemophilia A of any severity based on medical records
Pt in need of treatment with factor VIII or bypassing agent
Age above or equal to 12 years
Pt willing to discontinue emicizumab at screening
FVIII activity >1% on prophy: ≥1 bleed in the last 26 wks
Exclusion Criteria:
Female who is pregnant, breast-feeding or intends to become pregnant
Receipt of gene therapy at any given time point
Ongoing or planned ITI therapy
Previous or current thromboembolic disease or events
Participation in clinical trial within 30 days or 5 half-lives
Blood Disorders
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 1 location

Study Locations

Hide all locations
Location Contacts
Hershey, PA ,